🇺🇸 FDA
Patent

US 9452161

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61KA61K31/4545A61K45/06

Quick answer

US patent 9452161 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623